Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
Abbott to discontinue sale of probiotic products for infants after FDA warning
(Reuters) -Abbott Laboratories has agreed to discontinue sales of its Similac Probiotic Tri-Blend product used for hospitalized preterm infants after the U.S. Food and Drug Administration issued a war...
Oct 26, 2023
Labcorp beats quarterly profit estimates on strength in routine testing segment
(Reuters) - Laboratory Corporation of America topped Wall Street expectations for quarterly adjusted profit on Thursday, as strength in its routine diagnostics business more than offset weak COVID tes...
Oct 26, 2023
Bristol Myers says it needs another year to hit target for new drugs
By Michael Erman (Reuters) -Drugmaker Bristol Myers Squibb on Thursday pushed back by a year the time frame for its current new-product portfolio to hit $10 billion in sales as the ramp-up of new drug...
Oct 26, 2023
Births in Italy heading for new record low in 2023 – stats office
ROME (Reuters) - Births in Italy are heading for a new record low this year, according to preliminary data that points to a deepening of the country's long-standing demographic crisis. Between January...
Oct 26, 2023
Pfizer, BioNtech say flu-COVID shot generates immune response
(Reuters) - Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against the virus strains in early- to mid-stage trial...
Oct 26, 2023
Medical equipment maker West Pharmaceutical raises 2023 profit forecast
(Reuters) - Medical equipment maker West Pharmaceutical Services on Thursday raised its 2023 adjusted profit forecast for a third time, benefiting from a stronger dollar. The company, which makes prod...
Oct 26, 2023
Boston Scientific raises profit forecast on strength in heart devices unit
(Reuters) -Medical device maker Boston Scientific raised its annual profit forecast and beat estimates for third-quarter profit on Thursday as a post-pandemic rebound in elective surgeries bolstered d...
Oct 26, 2023
Kenvue cuts annual profit forecast on weakness in cold, flu meds demand
(Reuters) -Kenvue on Thursday cut its annual profit forecast, as it expects lower demand for its cough, cold and flu medicines and increased impact from a stronger dollar. Benadryl-maker Kenvue and pe...
Oct 26, 2023
Merck 3rd-quarter profit tops expectations on COVID pill surprise
By Michael Erman (Reuters) - Merck & Co on Thursday reported higher-than-expected third-quarter sales and profit on surprisingly strong demand for its COVID-19 treatment, primarily in Japan. The compa...
Oct 26, 2023
Japan’s Takeda slashes full-year profit forecast on drug pipeline impairments
TOKYO (Reuters) - Japan's biggest drugmaker Takeda Pharmaceutical on Thursday slashed its full-year profit forecast by 36% as it contends with disappointments in its development pipeline and the loss ...
Oct 26, 2023
